Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:41:49 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



C:AGN - Algernon Pharmaceuticals Inc. - http://www.algernonpharmaceuticals.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
AGN - C  8.00.14·0.156.50.1469.19150.13  0.145  0.130.25  0.0515:59:31Apr 2915 min RT 2¢
CSE - C8.00.14·0.156.50.1463.89110.14  0.145  0.140.25  0.0515:59:3115 min
Omega - O 0.13-0.01-7.13.0010.13  0.13  0.1310:00:3215 min
CX2 - H 0.142.0020.13  0.14  0.1310:23:5215 min
TriAct - M 0.140.31    Sep 01-2015 min

Recent Trades - Last 10 of 15
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:31C0.14 1,00068 Leede80 National BankK
15:00:52C0.14 11,00068 Leede19 DesjardinsK
14:18:05C0.1450.0052,00059 PI19 DesjardinsK
14:17:24C0.1450.00525,00059 PI7 TD SecK
13:38:26C0.14 2,00080 National Bank19 DesjardinsK
13:38:26C0.14 3,00059 PI19 DesjardinsK
11:26:55C0.14 30080 National Bank83 Research CapE
10:23:52H0.14 1,0007 TD Sec1 AnonymousK
10:23:52C0.14 8,0007 TD Sec19 DesjardinsK
10:23:52C0.14 9,0007 TD Sec19 DesjardinsK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-29 20:29C:AGN0.105SEDAR Interim MD & ASEDAR Interim MD & A
2024-04-29 19:52C:AGN0.105SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-04-01 09:37C:AGN0.11News ReleaseAlgernon to move forward with DMT stroke research
2024-03-27 12:20C:AGN0.09Resume TradingAlgernon Pharmaceuticals to resume at 9:45 a.m. PT
2024-03-27 12:17C:AGN0.12News ReleaseAlgernon sells ifenprodil research program to Seyltx
2024-03-27 10:24C:AGN0.09Halt TradingAlgernon Pharmaceuticals halted at 7:22 a.m. PT
2024-01-31 10:12C:AGN0.08News ReleaseAlgernon to receive Chinese repirinast patent
2024-01-11 10:22C:AGN0.085News ReleaseAlgernon receives notice of allowance in Japan
2023-12-29 17:56C:AGN0.065SEDAR MD & ASEDAR MD & A
2023-12-29 17:49C:AGN0.065SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2023-12-27 16:10C:AGN0.07News ReleaseAlgernon closes $280,000 private placement
2023-12-27 10:21C:AGN0.07News ReleaseAlgernon increases private placement to $280,000
2023-12-12 19:48C:AGN0.085News ReleaseAlgernon arranges $150,000 private placement
2023-11-30 09:50C:AGN0.07News ReleaseAlgernon to receive Chinese patent for Repirinast
2023-11-22 09:17C:AGN0.07News ReleaseAlgernon to sell ifenprodil research program to Seyltx
2023-11-08 10:30C:AGN0.075News ReleaseAlgernon receives Japanese patent for Repirinast
2023-09-06 09:54C:AGN0.16News ReleaseAlgernon receives U.S. patent for repirinast drug
2023-08-08 10:16C:AGN0.175News ReleaseAlgernon subsidiary finalizes phase 2 DMT stroke study
2023-07-28 16:29C:AGN0.20SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-07-14 18:12C:AGN0.22News ReleaseAlgernon arranges $205,000 private placement